Week 3 (Midterm) (Cholinergic) Flashcards
Parasympathetic (adrenergic) pre-ganglionic neurons secrete:
ACh (receptor is nicotinic)
Parasympathetic (adrenergic) post-ganglionic neurons secrete:
ACh (receptor on end organ is muscarinic)
Somatic pre-ganglionic neurons secrete:
ACh (receptor is nicotinic)
Somatic post-ganglionic neurons secrete:
ACh (receptor on end organ is nicotinic)
What does SLUDGE stand for?
Parasympathetic effects: Salvation Lacrimation Urination Defecation Gastrointestinal Emesis
Choline is transported into terminals via:
Na+/ACh symporter
Enzyme that converts choline to ACh
choline acetyltransferase
ACh packaging into vesicles via:
ACh/H+ antiporter
How is ACh released?
Calcium-mediated fusion of vesicles with cell membrane
ACh –> _____ (breakdown)
Choline and acetate (acetylcholinesterase)
What sympathetic NE receptor is on the heart?
Beta-1
What parasympathetic ACh receptor is on the heart?
M2
Hemicholinium action
inhibits Na+/ACh symporter - choline into synapse
Hemicholinium effect
ACh depletion
Vesamicol action
inhibits ACh/H+ antiporter - packaging into vesicles
Vesamicol effect
ACh depletion (no ACh packaged)
Botulinum toxin action
inhibits vesicle release
Botulinum toxin use
local treatment for spastic disorders, wrinkles
Botulinum toxin SE
paralysis
Latrotoxin/Beta-Bungarotoxin (spiders) action
Destroys synaptic vesicles
Latrotoxin/Beta-Bungarotoxin (spiders) effect
flooding of ACh into cleft, overload and synaptic failure
Latrotoxin/Beta-Bungarotoxin (spiders) SE
localized diaphoresis, weakness, myoclonus (weak twitching), local paresthesias (tingling), abd pain –> CV collapse, pulmonary edema, ileus (bowel blockage)
3,4-diaminopyridine action
promotes vesicle fusion, release of ACh
3,4-diaminopyridine use
treatment of Lambert Eaton Myasthenic Syndrome (autoantibodies to presynaptic Ca++ channels block ACh release)
Ganglionc agonists (used or nah?)
not clinically useful -effects are too systemic
- Nicotine (short term)
Nicotine (short term) mechanism
targets ganglionic nicotinic ACh receptors in CNS
Nicotine (short term) effects
mix of sympathetic/parasympathetic (effects decline with repeat dosage)
- CV: tachycardia/↑CO, BP
- nausea, vomiting, ↓GI motility
- diaphoresis
Muscarinic agonists - clinically useful?
ACh not clinically useful because of acetylcholinesterase; derivatives have more effects and are more resistant to break-down
Muscarine mechanism
Bind muscarinic receptors
Muscarine effect
activates receptors like ACh (SLUDGE)
Carbachol mechanism
bind muscarinic receptors and nicotinic “receptors” resistant to ACE
Carbachol use
experimental
Bethanecol mechanism
bind muscarinic receptors only
Bethanecol use
urinary retention, neurogenic (Bowel and Bladder)
Pilocarpine stability
VERY stable, lasts one day
Pilocarpine mechanism
bind muscarinic receptors only
Pilocarpine use
local open/closed angle glaucoma
Pilocarpine SE
If in CNS, cause distrubances, sweating, salivation
Anticholinesterases mechanism
inhibit acetylcholinesterase activity –> increase ACh signaling, SLUDGE effects
What is Anticholinesterase used to treat?
Myasthenia Gravis, a disorder where autoantiboeis degrade nAChR __> leads to ptosis, diplopia, fatigable chewing, respiratory crisis
Reversible - Short acting antiacetylcholinesterase
Edrophonium
10-20 min
Endrophonium
competes with autoantibodies
was used as a form of diagnosis
Reversible - medium acting anticholinesterase
Neostigmine
Pyridostigmine
Physostigmine
(2-6 hrs)
Neostigmine
Oral, used for MG, also for neurogenic ileus and post-op urinary retention
Pyridostigmine
Used for MG
Physostigmine
Used for glaucoma (topical), atropine poisoning
Irreversible anticholinesterases
Organophosphates
Organophosphates action
Irreversibly binds ACE active site, alkyl group released (irreversible aging) –> cholinergic stimulation then paralysis
Organophosphate uses
Insecticides, nerve gas, achothiophate (open-angle glaucoma)
Ganglionic antagonist
Nicotine (long term)
Hexamethonium
Trimethaphan
Nicotine (long term) mechanism
chronic stimulation leads to antagonism
GANGLIONIC ANTAGONIST
Hexamethonium use
antihypertensive (obsolete)
GANGLIONIC ANTAGONIST
Trimethaphan mechanism
Competitive ganglionic nACh receptor blocker (shorter acting, must be given IV)
GANGLIONIC ANTAGONIST
Trimethaphan use
emergent perioperative lowering of BP
Muscarinic Antagonists
Scopolamine
Atropine
MUSCARINIC ANTAGONISTS
Atropine mechanism
competitively binds and inhibits mAChR, lasts 4 hours (longer in eye)
MUSCARINIC ANTAGONISTS
Atropine use
eye: mydriasis, cycloplegia for eye exams bladder/GI: antispasmodic cholinergic overdose (mushroom/organophosphate poisoning) pre-op antisecretory agent for resp. tract
MUSCARINIC ANTAGONISTS
Atropine SE
- cutaneous flushing “red as a beet”
- fever “hot as a hare”
- CNS disturbances “Mad as a hatter”
- Dry mouth “dry as a bone”
- events in older pts with narrow angle glaucoma
MUSCARINIC ANTAGONISTS
Scopolamine use
Motion sickness, as amnesic in anesthesia
MUSCARINIC ANTAGONISTS
Scopolamine SE
like atropine + short-term memory loss
Neuromuscular antagonists
Curare (non-depolarizing)
Succinylcholine (depolarizing)
Non-depolarizing blockers - what do they do?
inhibit ACh Rs at motor end-plate –> causes flaccid paralysis that can be overcome with anticholinesterases
Curare use
from plants, muscle relaxxants in anesthesia
Depolarizing agents - what do they do?
bind and activate ACh Rs repeatedly (agonism)
Depolarizing agents - 2 phases
1) fasciculations
2) paralysis
(Channels inactivate with chronic stimulation)
Succinylcholine is acetylcholinesterase _____
resistant
Succinylcholine use
endotracheal intubation, anesthesia induction
Succinylcholine SE
malignant hyperthermia w/ halothane, apnea